ENALAPRIL - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC USE IN HYPERTENSION AND CONGESTIVE-HEART-FAILURE

被引：325
作者：
TODD, PA
HEEL, RC
机构：
来源：
DRUGS | 1986年 / 31卷 / 03期
关键词：
D O I：
10.2165/00003495-198631030-00002
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：198 / 248
页数：51
相关论文
共 281 条
[1]  
Abrams WB, 1984, J HYPERTENS S2, V2, P31
[2]  
AJAYI AA, 1984, BRIT J CLIN PHARMACO, V17, pP607
[3]  
ANDREN L, 1983, J HYPERTENS S2, V1, P384
[4]  
ARR SM, 1985, BRIT J CLIN PHARMACO, V20, pP279
[5]  
ARR SM, 1984, BRIT J CLIN PHARMACO, V18, pP292
[6]   NEW POTENT INHIBITORS OF ANGIOTENSIN CONVERTING ENZYME [J].
ATTWOOD, MR ;
FRANCIS, RJ ;
HASSALL, CH ;
KROHN, A ;
LAWTON, G ;
NATOFF, IL ;
NIXON, JS ;
REDSHAW, S ;
THOMAS, WA .
FEBS LETTERS, 1984, 165 (02) :201-206
[7]  
BARNES JN, 1983, LANCET, V2, P41
[8]  
BAUER JH, 1983, CLIN RES, V31, pA246
[9]   HEMODYNAMIC AND RENAL-FUNCTION IN ESSENTIAL-HYPERTENSION DURING TREATMENT WITH ENALAPRIL [J].
BAUER, JH ;
REAMS, GP .
AMERICAN JOURNAL OF MEDICINE, 1985, 79 (3C) :10-13
[10]  
BAUER JH, 1984, CLIN RES, V32, pA328
12345678910